Kpv vs TB-500 for pain & inflammation
Short answer: For pain & inflammation, more users report improvement with Kpv — 100% of 10 reports, versus 86% of 199 for TB-500.
Kpv has 1 meta-analyses and 0 randomized trials on PubMed; TB-500 has 0 and 3.
Based on 74 reports about Kpv and 874 about TB-500. Not medical advice.
| Kpv Peptide | TB-500 Peptide | |
|---|---|---|
| Users say it helped | 85%helped24 reports · medium confidence | 65%helped402 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 0 | 0 / 3 |
| Mainly used for | ||
| Recovery % reporting improvement | 100% (3) | 96% (297) |
| Pain & inflammation % reporting improvement | 100% (10) | 86% (199) |
| Performance % reporting improvement | — | 96% (26) |
| Skin & hair % reporting improvement | — | 88% (25) |
| Mood % reporting improvement | — | 91% (11) |
| Common side effects | malabsorption, green stool, weight loss, allergic reaction | anxiety, fatigue, dizziness, allergic reaction |
| Typical dose reported | Not listed | Not listed |
KpvFull Kpv profile →
Latest review conclusion
PCI using drug-eluting stents and CABG are equally safe methods of revascularization for patients at low surgical risk with significant unprotected left main coronary artery stenosis. However, CABG is associated with significantly lower rates of repeat revascularization.
Circ Cardiovasc Interv, 2016 ↗What a user said
“KPV has been my MVP (har-har). ... KPV helps tremendously. I’ve had a massive reduction in pain.”
TB-500Full TB-500 profile →
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate